Brief: Mabion Fulfills Condition For Deal With WPD Pharmaceuticals
19/05/2025 13:27
May 19 (Reuters) - Mabion SA MABP.WA: FULFILLS CONDITION FOR DEAL WITH WPD PHARMACEUTICALS AGREEMENT FOR ANALYTICAL METHOD DEVELOPMENT SERVICES NOW EFFECTIVE Source text: nEM5vWFnqa Further company coverage: MABP.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys